Occupational Exposure

New CDC Guidelines Established for HIV Exposure

Published in Medical Letter on the CDC and FDA, June 24th, 1996

Healthcare workers exposed to HIV in the workplace should receive chemoprophylaxis when the exposure is considered high-risk, according to U.S. Centers for Disease Control and Prevention (CDC) officials.

For exposure incidents that are associated with a low or negligible risk of HIV transmission, antiretroviral prophylaxis may not be necessary. The CDC has recommended that zidovudine be included in all chemoprophylaxis antiretroviral regimens. Treatment should be initiated promptly after exposure, preferably within one or two hours. Details were included in the CDC's Morbidity and Mortality Weekly Report (MMWR 1996;45:468-472).

Officials have...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1996-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry